infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: Estradiol valerate pretreatment (2mg oral estradiol twice daily from the 20th day of cycle until 1-4th day of new cycle. in short protocol GnRH-agonist cycles (150-225 IU/day hMG conti
Treatment - Drugs
Estradiol valerate pretreatment (2mg oral estradiol twice daily from the 20th day of cycle until 1-4th day of new cycle. in short protocol GnRH-agonist cycles (150-225 IU/day hMG continued with a dail
Combined pretreatment with oral contraceptive pills (Ovulostan from 2nd to 4th day of cycle) in long protocol GnRH-agonist cycles ( 0.1 mg Triptorelin beginning on the 14th day of the cycle, every 2 d
Sponsors
Invicta Fertility and Reproduction Centre sp.z o.o.
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion: women younger than 40 years old; an AMH level greater than 0.6 ng/mL; a body mass index between 18 and 29 kg/m2; first or second treatment cycle of IVF with intracytoplasmic sperm injection (ICSI). Exclusion: endometriosis; preimplantation diagnosis cycles
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy rate. Timepoint: on 6 weeks and 1-3 days. Method of measurement: clinical poregnancy (as ultrasound fetal heartbeat detection). | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation rate. Timepoint: 7 days after tansfer. Method of measurement: blood serum beta-HCG concentration. | — |
Countries
Poland
Contacts
Public ContactJudyta Zabielska
Invicta Fertility and Reproduction Centre sp.z o.o.
Outcome results
None listed